TY - STD TI - Guidance for industry, Developing medical imaging drugs and biological products, Part 1: conducting safety assessments, US Food and Drug Administration, http://www.fda.gov/downloads/Drugs/…/Guidances/ucm071600.pdf. UR - http://www.fda.gov/downloads/Drugs/%E2%80%A6/Guidances/ucm071600.pdf ID - ref1 ER - TY - STD TI - Guidance for Industry, Investigators and Reviewers, Exploratory IND studies, US Food and Drug Administration, http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm078933.pdf. UR - http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm078933.pdf ID - ref2 ER - TY - STD TI - Guideline on Immunogenicity assessment of biotechnology-derived therapeutic proteins, EMEA/CHMP/BMWP/14327/2006 Rev. 1, European Medicines Agency, http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500194507&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc. UR - http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500194507&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc ID - ref3 ER - TY - STD TI - Guideline on the limits for genotoxic impurities, CPMP/SWP/5199/02, European Medicines Agency, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002903.pdf. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002903.pdf ID - ref4 ER - TY - STD TI - ICH guideline M7 on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk, EMA/CHMP/ICH/83812/2013, European Medicines Agency, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/09/WC500173445.pdf. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/09/WC500173445.pdf ID - ref5 ER - TY - STD TI - ICH guideline S6 (R1) – preclinical safety evaluation of biotechnology-derived pharmaceuticals, EMA/CHMP/ICH/731268/1998, European Medicines Agency, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002828.pdf. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002828.pdf ID - ref6 ER - TY - STD TI - ICH guideline S9 on nonclinical evaluation for anticancer pharmaceuticals, CHMP/ICH/646107/08, European Medicines Agency, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500043471.pdf. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500043471.pdf ID - ref7 ER - TY - STD TI - Multidisciplinary ICH guidelines including M 7 can be found under http://www.ich.org/products/guidelines/multidisciplinary/article/multidisciplinary-guidelines.html. UR - http://www.ich.org/products/guidelines/multidisciplinary/article/multidisciplinary-guidelines.html ID - ref8 ER - TY - STD TI - Note for guidance on impurities in new drug products, CPMP/ICH/2738/99, European Medicines Agency, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002676.pdf. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002676.pdf ID - ref9 ER - TY - STD TI - Note for guidance on impurity testing in new drug substances, CPMP/ICH/2737/99, European Medicines Agency, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002675.pdf. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002675.pdf ID - ref10 ER - TY - STD TI - Note for guidance on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals, CPMP/ICH/286/95, European Medicines Agency, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002941.pdf. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002941.pdf ID - ref11 ER - TY - STD TI - Opinion on use of the threshold of toxicological concern (TTC) approach for human safety assessment of chemical substances with focus on cosmetics and consumer products, SCCP/1171/08, European Commission, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_092.pdf. UR - http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_092.pdf ID - ref12 ER -